共 232 条
[41]
Kim HS(2017)Role of endometriosis as a prognostic factor for post-progression survival in ovarian clear cell carcinoma Mol Clin Oncol 7 609-18
[42]
Kim MA(2017)Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma Gynecol Oncol 146 11-283
[43]
Lee M(2018)Significance of ovarian endometriosis on the prognosis of ovarian clear cell carcinoma Int J Gynecol Cancer 28 277-705
[44]
Suh DH(2020)Clinical characteristics of clear cell ovarian cancer: a retrospective multicenter experience of 308 patients in South Korea Cancer Res Treat 52 672-93
[45]
Kim K(2019)ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease† Ann Oncol 30 88-2993
[46]
No JH(2009)Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial Int J Gynecol Cancer 19 2985-298
[47]
Samson JA(2017)Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a surveillance, epidemiology, and end results cohort study, 2000–2013 Ann Oncol 28 293-undefined
[48]
Scott RB(2020)Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: a systematic review and meta-analysis Gynecol Oncol 157 undefined-undefined
[49]
Kondi-Pafiti A(undefined)undefined undefined undefined undefined-undefined
[50]
Papakonstantinou E(undefined)undefined undefined undefined undefined-undefined